Suppressing Cdk5 Activity by Luteolin Inhibits MPP+-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways

Autor: Pennapa Chonpathompikunlert, Pilaiwanwadee Hutamekalin, Ratchaneekorn Reudhabibadh, Thunwa Binlateh, Pithi Chanvorachote, Nongyao Nonpanya, Peerada Prommeenate
Jazyk: angličtina
Rok vydání: 2021
Předmět:
MAPK/ERK pathway
Dynamins
1-Methyl-4-phenylpyridinium
Cdk5
Pharmaceutical Science
medicine.disease_cause
Neuroprotection
Article
Analytical Chemistry
lcsh:QD241-441
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
lcsh:Organic chemistry
Drug Discovery
medicine
Humans
oxidative stress
Viability assay
Physical and Theoretical Chemistry
Phosphorylation
luteolin
Extracellular Signal-Regulated MAP Kinases
Protein kinase B
030304 developmental biology
0303 health sciences
Glycogen Synthase Kinase 3 beta
Dopaminergic Neurons
Organic Chemistry
Neurotoxicity
apoptosis
Cyclin-Dependent Kinase 5
Parkinson Disease
medicine.disease
1-methyl-4-phenylpyridinium ion
Cell biology
Neuroprotective Agents
chemistry
Chemistry (miscellaneous)
Focal Adhesion Protein-Tyrosine Kinases
Mitochondrial Membranes
Parkinson’s disease
Molecular Medicine
Luteolin
Proto-Oncogene Proteins c-akt
030217 neurology & neurosurgery
Oxidative stress
Signal Transduction
Zdroj: Molecules
Volume 26
Issue 5
Molecules, Vol 26, Iss 1307, p 1307 (2021)
ISSN: 1420-3049
DOI: 10.3390/molecules26051307
Popis: Parkinson’s disease (PD) is characterized by the progressive degeneration of dopaminergic neurons. The cause of PD is still unclear. Oxidative stress and mitochondrial dysfunction have been linked to the development of PD. Luteolin, a non-toxic flavonoid, has become interested in an alternative medicine, according to its effects on anti-oxidative stress and anti-apoptosis, although the underlying mechanism of luteolin on PD has not been fully elucidated. This study aims to investigate whether luteolin prevents neurotoxicity induction by 1-methyl-4-phenylpyridinium iodide (MPP+), a neurotoxin in neuroblastoma SH-SY5Y cells. The results reveal that luteolin significantly improved cell viability and reduced apoptosis in MPP+-treated cells. Increasing lipid peroxidation and superoxide anion (O2ˉ), including mitochondrial membrane potential (Δψm) disruption, is ameliorated by luteolin treatment. In addition, luteolin attenuated MPP+-induced neurite damage via GAP43 and synapsin-1. Furthermore, Cdk5 is found to be overactivated and correlated with elevation of cleaved caspase-3 activity in MPP+-exposed cells, while phosphorylation of Erk1/2, Drp1, Fak, Akt and GSK3β are inhibited. In contrast, luteolin attenuated Cdk5 overactivation and supported phosphorylated level of Erk1/2, Drp1, Fak, Akt and GSK3β with reducing in cleaved caspase-3 activity. Results indicate that luteolin exerts neuroprotective effects via Cdk5-mediated Erk1/2/Drp1 and Fak/Akt/GSK3β pathways, possibly representing a potential preventive agent for neuronal disorder.
Databáze: OpenAIRE